VEL-101

DRUG2 trials

Sponsors

Veloxis Pharmaceuticals

Conditions

Healthy VolunteersTransplantation, Kidney

Phase 1

A Dose Escalation Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of VEL-101

CompletedNCT05238493

Veloxis PharmaceuticalsHealthy Volunteers

Start: 2022-04-26End: 2023-01-03Updated: 2024-06-27

Phase 2

VEL-101 to Prevent Rejection After Kidney Transplantation

Not yet recruitingNCT07290777

Veloxis PharmaceuticalsTransplantation, Kidney

Start: 2026-07-31End: 2028-10-31Target: 120Updated: 2025-12-18